Systemic treatment of advanced non-small cell lung cancer.
about
A new PET/CT volumetric prognostic index for non-small cell lung cancer18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.Prognostic value of metabolic tumor burden in lung cancer.Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.Assessment of pulmonary 18F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib.
P2860
Systemic treatment of advanced non-small cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Systemic treatment of advanced non-small cell lung cancer.
@ast
Systemic treatment of advanced non-small cell lung cancer.
@en
type
label
Systemic treatment of advanced non-small cell lung cancer.
@ast
Systemic treatment of advanced non-small cell lung cancer.
@en
prefLabel
Systemic treatment of advanced non-small cell lung cancer.
@ast
Systemic treatment of advanced non-small cell lung cancer.
@en
P1433
P1476
Systemic treatment of advanced non-small cell lung cancer.
@en
P2093
Anne M Traynor
Joan H Schiller
P304
P577
2004-08-01T00:00:00Z